SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-239806
Filing Date
2021-08-09
Accepted
2021-08-09 06:06:31
Documents
14
Period of Report
2021-08-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d174014d8k.htm   iXBRL 8-K 29500
2 EX-99.1 d174014dex991.htm EX-99.1 6392
6 GRAPHIC g174014g56l39.jpg GRAPHIC 13236
  Complete submission text file 0001193125-21-239806.txt   185686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atha-20210804.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atha-20210804_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atha-20210804_pre.xml EX-101.PRE 11875
7 EXTRACTED XBRL INSTANCE DOCUMENT d174014d8k_htm.xml XML 3475
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 211154490
SIC: 2836 Biological Products, (No Diagnostic Substances)